Skip to main content
All lobbying filings

IPOLICY SOLUTIONS

IPOLICY SOLUTIONS filed a Q1 report for ASSOCIATION FOR MOLECULAR PATHOLOGY on April 11, 2025, reporting $70,500 in lobbying income.

Lobbying for ASSOCIATION FOR MOLECULAR PATHOLOGY · A medical subspecialty professional society

All filings by IPOLICY SOLUTIONS · Everything ASSOCIATION FOR MOLECULAR PATHOLOGY has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 11, 2025
Income
$70,500
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Lobbyists on this filing 1
  • JENNIFER RACHEL LEIB
    Previously held: Fellow, Senate Committee on Health, Education, Labor, and Pensions

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4
Medical/Disease Research/Clinical Labs

No bill #: legislation to clarify CLIA FDA Final Rule: Laboratory Developed Tests S.J.Res.82 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests" HR 1463: Freedom for Laboratory Innovation and Testing Act

Copyright/Patent/Trademark

No bill #: Patent Eligibility Restoration Act

Budget/Appropriations

No bill number: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Health Issues

HR 2471: Right Drug Dose Now Act

 Bills named in this filing 3
  • S.J. Res. 82
    A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule …
  • H.R. 1463
    To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administrat…
  • H.R. 2471
    Right Drug Dose Now Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem